Issue 38, 2011

High throughput discovery of heteroaromatic-modifying enzymes allows enhancement of novobiocin selectivity

Abstract

Glycosylated analogues of novobiocin, discovered using a broad library of enzymes, have 100-fold improved activity against breast, brain, pancreatic, lung and ovarian cancers and ablated associated off-target activity leading to an up to 2.7 × 104 fold increase in selectivity.

Graphical abstract: High throughput discovery of heteroaromatic-modifying enzymes allows enhancement of novobiocin selectivity

Supplementary files

Article information

Article type
Communication
Submitted
15 Jun 2011
Accepted
29 Jul 2011
First published
24 Aug 2011

Chem. Commun., 2011,47, 10569-10571

High throughput discovery of heteroaromatic-modifying enzymes allows enhancement of novobiocin selectivity

S. M. Patel, M. D. L. Fuente, S. Ke, A. M. R. Guimarães, A. O. Oliyide, X. Ji, P. Stapleton, A. Osbourn, Y. Pan, D. J. Bowles, B. G. Davis, A. Schatzlein and M. Yang, Chem. Commun., 2011, 47, 10569 DOI: 10.1039/C1CC13552J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements